201 related articles for article (PubMed ID: 30478530)
1. Preferences for Surveillance of Barrett's Oesophagus: a Discrete Choice Experiment.
Bulamu NB; Chen G; Bright T; Ratcliffe J; Chung A; Fraser RJL; Törnqvist B; Watson DI
J Gastrointest Surg; 2019 Jul; 23(7):1309-1317. PubMed ID: 30478530
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
3. A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance.
Gudlaugsdottir S; van Blankenstein M; Dees J; Wilson JH
Eur J Gastroenterol Hepatol; 2001 Jun; 13(6):639-45. PubMed ID: 11434588
[TBL] [Abstract][Full Text] [Related]
4. Barrett's oesophagus: a review of costs of the illness.
Arguedas MR; Eloubeidi MA
Pharmacoeconomics; 2001; 19(10):1003-11. PubMed ID: 11735670
[TBL] [Abstract][Full Text] [Related]
5. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.
Ross-Innes CS; Chettouh H; Achilleos A; Galeano-Dalmau N; Debiram-Beecham I; MacRae S; Fessas P; Walker E; Varghese S; Evan T; Lao-Sirieix PS; O'Donovan M; Malhotra S; Novelli M; Disep B; Kaye PV; Lovat LB; Haidry R; Griffin M; Ragunath K; Bhandari P; Haycock A; Morris D; Attwood S; Dhar A; Rees C; Rutter MD; Ostler R; Aigret B; Sasieni PD; Fitzgerald RC;
Lancet Gastroenterol Hepatol; 2017 Jan; 2(1):23-31. PubMed ID: 28404010
[TBL] [Abstract][Full Text] [Related]
7. How to get the most out of costly Barrett's oesophagus surveillance.
Braden B; Jones-Morris E
Dig Liver Dis; 2018 Sep; 50(9):871-877. PubMed ID: 29730158
[TBL] [Abstract][Full Text] [Related]
8. Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.
Inadomi JM
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):51-63. PubMed ID: 25743456
[TBL] [Abstract][Full Text] [Related]
9. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
[TBL] [Abstract][Full Text] [Related]
10. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.
Fitzgerald RC; di Pietro M; Ragunath K; Ang Y; Kang JY; Watson P; Trudgill N; Patel P; Kaye PV; Sanders S; O'Donovan M; Bird-Lieberman E; Bhandari P; Jankowski JA; Attwood S; Parsons SL; Loft D; Lagergren J; Moayyedi P; Lyratzopoulos G; de Caestecker J;
Gut; 2014 Jan; 63(1):7-42. PubMed ID: 24165758
[TBL] [Abstract][Full Text] [Related]
11. Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment.
Peters Y; Siersema PD
Clin Transl Gastroenterol; 2020 Nov; 11(11):e00260. PubMed ID: 33105164
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer.
Streitz JM; Ellis FH; Tilden RL; Erickson RV
Am J Gastroenterol; 1998 Jun; 93(6):911-5. PubMed ID: 9647017
[TBL] [Abstract][Full Text] [Related]
13. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
Rana PS; Johnston DA
Dis Esophagus; 2000; 13(1):28-31. PubMed ID: 11005328
[TBL] [Abstract][Full Text] [Related]
14. Barrett's oesophagus: epidemiology, cancer risk and implications for management.
de Jonge PJ; van Blankenstein M; Grady WM; Kuipers EJ
Gut; 2014 Jan; 63(1):191-202. PubMed ID: 24092861
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for Barrett's oesophagus: results from a programme in Northern Ireland.
Murphy SJ; Dickey W; Hughes D; O'Connor FA
Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1029-35. PubMed ID: 16148547
[TBL] [Abstract][Full Text] [Related]
16. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
17. Management of Barrett's oesophagus in 2001 in Ireland.
Moss A; Clarke E; Crowe J; Lennon J; Mac Mathuna P
Ir J Med Sci; 2003; 172(4):174-6. PubMed ID: 15029984
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing dysplasia in Barrett's oesophagus still requires Seattle protocol biopsy in the era of modern video endoscopy: results from a tertiary centre Barrett's dysplasia database.
Nachiappan A; Ragunath K; Card T; Kaye P
Scand J Gastroenterol; 2020 Jan; 55(1):9-13. PubMed ID: 31880176
[No Abstract] [Full Text] [Related]
19. Confocal laser endomicroscopy for in vivo diagnosis of Barrett's oesophagus and associated neoplasia: a pilot study conducted in a single Italian centre.
Trovato C; Sonzogni A; Ravizza D; Fiori G; Tamayo D; De Roberto G; de Leone A; De Lisi S; Crosta C
Dig Liver Dis; 2013 May; 45(5):396-402. PubMed ID: 23352281
[TBL] [Abstract][Full Text] [Related]
20. Are screening and surveillance for Barrett's oesophagus really worthwhile?
Sharma P; Sidorenko EI
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
